TELA Bio (TELA) Return on Capital Employed (2019 - 2026)

TELA Bio's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 58.47% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 3763.0% year-over-year to 58.47%; the TTM figure through Mar 2026 stood at 58.47% (down 3763.0% YoY), while the FY2025 annual figure was 51.13%, down 3917.0% from the prior year.
• Return on Capital Employed was 58.47% for Q1 2026 at TELA Bio, up from 63.06% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 14.72% in Q4 2024 to a low of 95.69% in Q3 2024.
• Historically, Return on Capital Employed has averaged 58.31% across 5 years, with a median of 63.63% in 2022.
• Biggest YoY gain for Return on Capital Employed was 7610 bps in 2025; the steepest drop was 4834 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 63.63% in 2022, then decreased by 5 bps to 67.07% in 2023, then soared by 78 bps to 14.72% in 2024, then plunged by 328 bps to 63.06% in 2025, then advanced by 7 bps to 58.47% in 2026.
• The last three Return on Capital Employed figures came in at 58.47% (Q1 2026), 63.06% (Q4 2025), and 19.59% (Q3 2025), per Business Quant data.